1. Product Mechanism & Key Ingredients

The product contains anhydride-modified bioactive protein. After modification, the protein surface carries negative charges, which can bind with the positively charged sites on Human Papillomavirus (HPV), causing structural changes to HPV proteins and thereby blocking HPV infection.

Carbomer provides excellent adhesion and film-forming properties, helping encapsulate and remove inactivated HPV particles.

Glycerin helps regulate the gel texture and stability.

This product is intended to help reduce local HPV viral load.

2. Expected Functions & Product Benefits

Barrier Protection

• Assists in the management of high-risk genital HPV infections

• Supports treatment of low-grade cervical lesions caused by high-risk HPV (CIN I)

Pathogen Adsorption

• Helps block genital HPV infection

• Assists in reducing the risk of cervical precancerous lesions (CIN) and cervical cancer

Metabolic Elimination

• Improves the vaginal microenvironment

• Helps reduce inflammatory reactions and vaginal discharge

• Supports vaginal cleanliness and lowers vaginal pH value

Anti-inflammatory & Repair Support

• Helps relieve vaginal odor and itching caused by various vaginal inflammations

Product Benefits

• Helps inhibit HPV activity

• Supports control of other reproductive tract inflammations

• Promotes repair of reproductive tract mucosal damage

• Helps restore vaginal microecological balance and healthy flora

• 

3. Technology Background

The bioactive protein is derived from lactoferrin in milk. Lactoferrin contains more than 690 amino acid residues. Even in its natural form, lactoferrin can inhibit the binding of certain viruses to host cells and reduce infectious inflammation.

Through advanced modification technology, the protein modification rate reaches over 98.98%, exceeding comparable products reported in literature (approximately 95%). The modified protein surface carries abundant negative charges, enabling strong interaction with HPV and demonstrating excellent biological activity.

4. Recommended Usage, Storage & Notes

Recommended Usage

For HPV management, treatment is recommended in cycles:

• Start use 3 days after menstruation ends
• Apply 1 tube every other day before bedtime
• 10 applications constitute one treatment course
• After one course, pause until 3 days after the next menstruation, then begin the next course
• 3 consecutive courses are recommended as one full treatment cycle
• Re-examination is recommended after 2–3 months

Storage

Store in a cool, dry place away from direct sunlight.

Note

For external vaginal use only. Please follow professional medical advice before use.